Irom Pharmaceuticals Limited - Company Profile

It is a chemicals private limited company based in Assam, Assam, India, established in 2013.
2013 Assam, Assam, India Active
Last Updated:
Access Report
About Irom Pharmaceuticals Limited

Irom Pharmaceuticals Limited, a active private limited company, was established on 18 January 2013 in Assam, Assam, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230AS2013PTC011403. Registered under ROC Roc Guwahati. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.

Its leadership includes Irom Kunjalata Chanu (Director), Irom Ramananda Meitei (Director), Irom Khaba Meitei (Director). Its latest AGM occurred on 30 September 2014, with the balance sheet filed on 31 March 2014. It is based at Jharagul Bazar, P.O. Jharagul, P.S. Sonai, Assam, Assam, 788119.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230AS2013PTC011403

  • Registration Number

    011403

  • Incorporation Date

    18 January 2013

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Guwahati

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 13 Year, 4 Months
  • Last Filing with ROC 31 Mar 2014
Company report

Irom Pharmaceuticals Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Irom Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Irom Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Irom Kunjalata Chanu Director 18 Jan 2013 Current
Irom Ramananda Meitei Director 18 Jan 2013 Current
Irom Khaba Meitei Director 18 Jan 2013 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Irom Pharmaceuticals.

Enhance accessibility to Irom Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Irom Pharmaceuticals revenue growth over time
Irom Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Irom Pharmaceuticals?

Unlock access to Irom Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Irom Pharmaceuticals?

Unlock and access historical data on people associated with Irom Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Irom Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Irom Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Irom Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Irom Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records. was documented.

  • Balance Sheet

    Irom Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Guwahati. was recorded as a recent event.

  • Director Appointment

    Irom Kunjalata Chanu was appointed as a Director was appointed as a Director on 18 Jan 2013 & has been associated with this company since 13 years 4 months . was recorded as a recent event.

  • Director Appointment

    Irom Ramananda Meitei was appointed as a Director was appointed as a Director on 18 Jan 2013 & has been associated with this company since 13 years 4 months . was recorded as a recent event.

  • Director Appointment

    Progress on Irom Khaba Meitei was appointed as a Director was appointed as a Director on 18 Jan 2013 & has been associated with this company since 13 years 4 months . was documented.

  • Company Incorporation

    The activity Irom Pharmaceuticals Limited was registered on 18 Jan 2013 with Roc Guwahati & aged 13 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Irom Pharmaceuticals Limited?

The CIN of Irom Pharmaceuticals Limited is U24230AS2013PTC011403.

Where is Irom Pharmaceuticals Limited headquartered?

Irom Pharmaceuticals Limited is headquartered at Jharagul Bazar, P.O. Jharagul, P.S. Sonai, Assam, Assam, 788119.

When was Irom Pharmaceuticals Limited incorporated?

Irom Pharmaceuticals Limited was incorporated on 18 January 2013.

Who are the current directors of Irom Pharmaceuticals Limited?

The current directors of Irom Pharmaceuticals Limited are

What is the primary industry of Irom Pharmaceuticals Limited?

The primary industry of Irom Pharmaceuticals Limited is Chemicals.

Is Irom Pharmaceuticals Limited a listed company?

Irom Pharmaceuticals Limited is unlisted.

What is the capital structure of Irom Pharmaceuticals Limited?

The authorized capital of Irom Pharmaceuticals Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available